Flexion Therapeutics (FLXN) Misses Q1 EPS by 17c

Flexion Therapeutics (NASDAQ: FLXN) reported Q1 EPS of ($0.78), $0.17 worse than the analyst estimate of ($0.61).

For earnings history and earnings-related data on Flexion Therapeutics (FLXN) click here.

You May Also Be Interested In

• Fox upgraded to overweight as Roku deal, ad strength lift outlook
• Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
• Cheetah Net Supply Chain Service Inc. (CTNT) Reports Q2 EPS of $0.04